265O Anlotinib in locally advanced or metastatic radioiodine-refractory differentiated thyroid carcinoma: A randomized, double-blind, multicenter phase II trial

Y. Chi, Ming Gao, Y. Zhang, Feng Shi, Ying Cheng, Zhixing Guo, Minghua Ge, Jianwu Qin, J. Zhang, Zeyu Li,

Annals of Oncology · 2020 · 10 citations · 0 references

Concepts